A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Phase 2
- Conditions
- Health Condition 1: null- Adenoviral Conjunctivitis
- Registration Number
- CTRI/2012/11/003145
- Lead Sponsor
- ovaBay Pharmaceutical Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 440
Inclusion Criteria
1. Subjects must be >= 18 years of age and <= 65 years of age
2. At least 1 eye (and in that same eye) must have onset and development of ocular symptoms and/or signs of conjunctivitis <= 3 days prior to enrollment (Day 1)
3. Females who are not pregnant and are not lactating.
4. Other inclusion criteria per protocol.
Exclusion Criteria
1.Presence of subepithelial infiltrates (SEIs) at the Day 1 visit in either eye.
2.Suspected bacterial, fungal, herpes, Chlamydia or Acanthamoeba co-infection, based on clinical observation.
3.Subjects with ocular condition(s) that may interfere with the conduct of the study as outlined in the protocol.
4.Other exclusion criteria per protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method